Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
- J. Michael Gaziano,
- Anthony H. Cincotta,
- Christopher M. O’Connor,
- Michael Ezrokhi,
- Dean Rutty,
- Z.J. Ma and
- Richard E. Scranton
In Table 2 of the article cited above, there is an error in the calculation of the percent of subjects meeting a study end point. The placebo value for “Hospitalization for congestive heart failure” is 6 (0.4) in the original table presentation. The correct value is 6 (0.6).
The section of the corrected table is presented below.
View this table:
- © 2016 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
In this Issue
October 2016, 39(10)
Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
